OCC

2.67%

36.5¢

ORTHOCELL LIMITED

Market Cap $76.49M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Latest Threads

Tag

Subject

OCC

OCC Trading

28 29 30

13:26

1.7K

535K

13:26

Last post Jalaluddin

1.7K

535K

OCC

Media thread

9 10 11

20/08/24

600

201K

20/08/24

Last post Eqz

600

201K

OCC

Ann: Remplir Expansion Continues with Singapore Application

17/08/24

9.1K

17/08/24

Last post scolloymore

9.1K

OCC

Stem Cell Therapy advancements

6 7 8

16/08/24

475

165K

16/08/24

Last post bedger

475

165K

OCC

Ann: Application for quotation of securities - OCC

11/08/24

1.3K

11/08/24

Last post scolloymore

1.3K

OCC

Ann: Notification regarding unquoted securities - OCC

08/08/24

236

08/08/24

Last post

ASX News

236

OCC

News: OCC Orthocell's Application In Singapore Accepted For Review By HSA

29/07/24

1.1K

29/07/24

Last post 2oo3

1.1K

OCC

Ann: Striate Expansion Continues with Singapore Application

29/07/24

406

29/07/24

Last post

ASX News

406

See All Discussions

Timeline

Notification regarding unquoted securities - OCC
08 Aug 17:31	Share

Application for quotation of securities - OCC
08 Aug 17:28	Share

Striate Expansion Continues with Singapore Application
29 Jul 09:01	Share

Global Market Expansion Accelerates - New Regions Pending
24 Jul 08:58	Share

Quarterly Activity Report & Appendix 4C
16 Jul 09:33	Share

Regulatory Approval to Commence Sales for Striate in Canada
11 Jul 09:37	Share

Trading Halt
10 Jul 11:00	Share

Pause in Trading
10 Jul 10:46	Share

Record Quarterly and Yearly Revenue Show Outstanding Growth
09 Jul 09:05	Share

Notification regarding unquoted securities - OCC
12 Jun 08:24	Share

Proposed issue of securities - OCC
11 Jun 15:58	Share

Third Revenue Generating Product to be Launched in SmrtGraft
11 Jun 08:56	Share

Notification of cessation of securities - OCC
05 Jun 08:26	Share

Outstanding 98.6% Success Rate in Striate Implant Study
14 May 09:05	Share

Compelling 85% Success Rate Remplir Study now published
30 Apr 09:49	Share

Change of Director's Interest Notice-John Van Der Wielen
24 Apr 11:52	Share

Securities Trading Policy
24 Apr 11:23	Share

Change of Director's Interest Notice-John Van Der Wielen
16 Apr 08:56	Share

Orthocell receives $3.05m R&D tax incentive refund
15 Apr 09:03	Share

Quarterly Activity Report & Appendix 4C
08 Apr 09:03	Share

Part 1 Remplir US Market Authorisation Successfully Complete
25 Mar 09:19	Share

Cleansing Notice
11 Mar 18:06	Share

Application for quotation of securities - OCC
11 Mar 18:05	Share

Application for quotation of securities - OCC
11 Mar 18:04	Share

Cleansing Notice
28 Feb 10:27	Share

Application for quotation of securities - OCC
28 Feb 10:24	Share

Appendix 4D & Half-Year Financial Statements
23 Feb 15:27	Share

Proposed issue of securities - OCC
22 Feb 09:20	Share

Strategic Placement to Raise $3.5 million
22 Feb 09:20	Share

Trading Halt
20 Feb 09:43	Share

View More

(20min delay)
Last 36.5¢		Change -0.010(2.67%)		Mkt cap ! $76.49M

Open	High	Low	Value	Volume
37.0¢	37.0¢	36.5¢	$9.932K	27.02K

Buyers (Bids)

No.	Vol.	Price($)
2	29838	36.5¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	5465	2

View Market Depth

No.	Vol.	Price($)
1	27099	0.365
6	113240	0.360
5	59319	0.355
7	91882	0.350
2	31889	0.345

Price($)	Vol.	No.
0.375	5465	2
0.380	19190	2
0.390	29373	5
0.395	30226	2
0.400	71786	4

Last trade - 14.41pm 23/08/2024 (20 minute delay)


Last 36.5¢		Change -0.010 ( 2.67 %)
Open	High	Low	Volume
37.0¢	37.0¢	36.5¢	21850
Last updated 15.24pm 23/08/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Orthocell (ASX:OCC) shares jumped close to 5% heading into afternoon trade as the company flagged record yearly revenues.

Orthocell's Remplir shows 85% success rate in nerve repair study

Orthocell's medical device RemplirTM shows 85% success rate in latest nerve repair study, holding a promise for millions of individuals

Orthocell (ASX:OCC) launches fresh rat nerve-repair study

Regenerative medicine company Orthocell (ASX:OCC) has begun a 'comparator' study as part of its pre-clinical and clinical development program in nerve repair and regeneration.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News